The World of Health & Medicine News

Researchers Find That a Common Nutrient in Food Is Linked to Depression

Researchers Find That a Common Nutrient in Food Is Linked to Depression

Proline, an amino acid abundant in many foods, has been linked to depression through its interaction with gut bacteria and brain chemistry.

The findings reveal that controlling proline levels or its transport to the brain could help prevent or treat depression.

A Surprising Link Between Proline and Depression

Researchers at the Girona Biomedical Research Institute (IDIBGI) and Pompeu Fabra University (UPF) in Barcelona, Spain, have identified a surprising connection between an amino acid and depression in humans, mice, and fruit flies. The compound, called proline, is found in many common foods, including gelatin, grass-fed beef, and wild-caught fish. Their research, published in Cell Metabolism, suggests that diets rich in proline may raise the likelihood of developing depressive symptoms.

Dr. José Manuel Fernández-Real and Dr. Jordi Mayneris-Perxachs from the IDIBGI and CIBEROBN research groups on Nutrition, Eumetabolism, and Health led the investigation, along with Dr. Rafael Maldonado of UPF’s Neuropharmacology-Neurophar research group, which is linked to the Hospital de la Mar Medical Research Institute (IMIM).

spot_img

Explore more

spot_img

US FDA approves Omeros’ drug to treat dangerous transplant complication

US FDA approves Omeros' drug to treat dangerous transplant complication The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication,...

WHO hosts the second Global Summit to advance evidence, integration and...

WHO hosts the second Global Summit to advance evidence, integration and innovation for traditional medicine The World Health Organization (WHO)’s Second Global Summit on Traditional Medicine,...

Novo Nordisk wins US approval for weight-loss pill

Novo Nordisk wins US approval for weight-loss pill The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday, giving ​the Danish drugmaker...

Takeda’s AI-crafted psoriasis pill succeeds in late-stage studies

Takeda's AI-crafted psoriasis pill succeeds in late-stage studies Japan's Takeda Pharmaceutical (4502.T), opens new tab said on Thursday its experimental pill for a type of skin disease,...

US FDA approves Cytokinetics’ heart disease drug

US FDA approves Cytokinetics' heart disease drug The U.S. Food and Drug ​Administration has approved ‌Cytokinetics' drug to treat a ‌rare heart condition, the company...

GSK wins US approval for twice-yearly asthma drug

GSK wins US approval for twice-yearly asthma drug  The U.S. health regulator has approved GSK's (GSK.L), opens new tab add-on treatment for severe asthma, offering a less...

US CDC ends guidance that all newborns should get hepatitis B...

US CDC ends guidance that all newborns should get hepatitis B vaccine, in major policy shift The U.S. Centers for Disease Control and Prevention on...

FDA Approves J&J’s Akeega for Expanded Use in Prostate Cancer

FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate...